Related Experiment Video
Updated: Dec 17, 2025

04:41
Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
Published on: December 13, 2024
2.7K
Generating ventral spinal organoids from human induced pluripotent stem cells.
1Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore; Department of Biological Sciences, National University of Singapore, Singapore.
Methods in Cell Biology
|June 27, 2020
Summary
Human pluripotent stem cell technology enables the creation of spinal organoids, valuable tools for studying spinal cord development and diseases like Spinal Muscular Atrophy.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Neuroscience
Background:
- Human pluripotent stem cells (hPSCs) offer a powerful model for studying human development.
- Spinal cord organoids recapitulate key aspects of human spinal cord development and cytoarchitecture.
- These organoids are crucial for modeling motor neuron diseases.
Purpose of the Study:
- To provide a detailed methodology for generating three-dimensional spinal organoids from hPSCs.
- To highlight the advantages and limitations of using spinal organoids in research.
- To offer guidance on technical and design considerations for spinal organoid generation.
Main Methods:
- Directed differentiation of hPSCs into spinal organoids.
- Culturing organoids in three-dimensional systems to mimic the spinal cord microenvironment.
- Detailed step-by-step protocol for organoid generation.
Main Results:
- Successful generation of spinal organoids that mimic human spinal cord structure.
- Demonstration of spinal organoids as a tool for disease modeling.
- Identification of key technical considerations for reproducible organoid generation.
Conclusions:
- Spinal organoids are a promising tool for advancing our understanding of human spinal cord development and disease.
- The described methodology facilitates the generation of these complex models.
- Further research utilizing spinal organoids can accelerate the development of therapies for motor neuron diseases.

